TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population

BACKGROUND: Tumours contain stem-like, side population (SP) cells, which have increased tumorigenic potential, resistance to traditional therapies and may be responsible for treatment failures and relapse in patients. METHODS: Mesenchymal stem cells (MSCs) were engineered to express the apoptotic li...

Descripción completa

Detalles Bibliográficos
Autores principales: Loebinger, M R, Sage, E K, Davies, D, Janes, S M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994223/
https://www.ncbi.nlm.nih.gov/pubmed/21063402
http://dx.doi.org/10.1038/sj.bjc.6605952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994223/
https://www.ncbi.nlm.nih.gov/pubmed/21063402
http://dx.doi.org/10.1038/sj.bjc.6605952

Ejemplares similares